PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $11,583 | -31.9% | 300 | 0.0% | 0.00% | -20.0% |
| Q2 2022 | $17,000 | -26.1% | 300 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $23,000 | +27.8% | 300 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $18,000 | +5.9% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $17,000 | -5.6% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $18,000 | -14.3% | 300 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $21,000 | +16.7% | 300 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $18,000 | 0.0% | 300 | 0.0% | 0.00% | -20.0% |
| Q3 2020 | $18,000 | +12.5% | 300 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $16,000 | +60.0% | 300 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $10,000 | -28.6% | 300 | 0.0% | 0.01% | -16.7% |
| Q4 2019 | $14,000 | +27.3% | 300 | 0.0% | 0.01% | +20.0% |
| Q3 2019 | $11,000 | -15.4% | 300 | 0.0% | 0.01% | -28.6% |
| Q2 2019 | $13,000 | +18.2% | 300 | 0.0% | 0.01% | +16.7% |
| Q1 2019 | $11,000 | -15.4% | 300 | 0.0% | 0.01% | -25.0% |
| Q4 2018 | $13,000 | – | 300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
| Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
| GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
| DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
| NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
| Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
| Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |